By using Prascend® as part of your PPID management protocol, you can help reduce the signs of PPID and improve horses’ quality of life.1
Horses Treated with PRASCEND:
PRASCEND is for use in horses only. Treatment with PRASCEND may cause loss of
appetite. Most cases are mild. Weight loss, lack of energy, and behavioral changes also may be
observed. If severe, a temporary dose reduction may be necessary. PRASCEND has not been
evaluated in breeding, pregnant, or lactating horses and may interfere with reproductive
hormones in these horses. PRASCEND Tablets should not be crushed due to the potential for
increased human exposure. Refer to package insert for complete
Benefits of early treatment
When it comes to treating PPID, the earlier the better. Although some early signs
can be managed (eg, extra clipping and grooming will control hypertrichosis), a case can be made
in support of starting medical treatment when clinical signs are initially
recognized.2 Early treatment can minimize progression of PPID and prolong the life of
When caught early, PPID treatment is very successful in reducing common signs and allowing affected horses to live normal lives.2 Even when a horse has advanced disease, treatment usually gives him a longer, healthier life.3
If you are caring for a horse who has been diagnosed with PPID, scheduling regular veterinary visits is important. Your veterinarian will regularly check on your horse to ensure proper dosing and that clinical signs are not advancing. Working with your veterinarian is key to managing PPID.
Helpful Tips for Managing PPID
As a horse owner, you can play a key role in keeping your horse healthy and active at any age. Visit with your veterinarian about a treatment plan but a few simple steps you can take to ensure your horse is in the best health possible include:
Your veterinarian will advise you on a customized diet and exercise plan that will help your horse maintain the correct weight. Horses with PPID often do well on the low-sugar, low-starch diets if considered to be prone to laminitis.3
PRASCEND® (pergolide mesylate) [Freedom of Information Summary]. St. Joseph, MO: Boehringer
Ingelheim Vetmedica, Inc.; 2011.
2. Schott HC. Pars pituitary intermedia dysfunction: challenges of diagnosis and treatment. In: Proceedings from the 52nd American Association of Equine Practitioners Annual Convention; December 2-6, 2006; San Antonio, TX.
3. McFarlane D. equine pituitary pars intermedia dysfunction. Vet Clin North Am Equine Pract. 2011;27(1):93–113
Enter your email below, and we will send you your new password.
Your password has been sent.
You haven't entered all required information for the horse you tried to submit. Please enter missing information and try again.